Skip to main content
. 2022 Mar 17;32(6):543–554. doi: 10.1038/s41422-022-00639-5

Fig. 7. VEGF-C mRNA significantly promotes T cell function in glioma after RT.

Fig. 7

a Percentage of the top 50 most frequent clones of CD3β in tumors from Ctr mRNA or VEGF-C mRNA groups on day 22 after inoculation (n = 3). b Comparison of CDR3β clonotype numbers in tumors from Ctr mRNA or VEGF-C mRNA groups on day 22 after inoculation (n = 3). c Quantification of CD8+ T cells expressing multiple cytokines in tumors from Ctr mRNA or VEGF-C mRNA groups on day 22 after inoculation (n = 6). d Illustration of the role of MLVs in brain tumors with RT. The MLV-CLN network mediates the RT-modulated anti-tumor immunity and contributes to RT efficacy. Data are presented as means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001; Student’s t-test (b, c). Data are from at least two (c) independent experiments.